Bulletin
Investor Alert

Vanda Pharmaceuticals Inc.

NAS: VNDA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200957783/composite

$

9.32

Change

0.00 0.00%

Volume

Volume 50,427

Sep 25, 2020, 4:16 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200957783/composite

Previous close

$ 9.36

$ 9.32

Change

-0.04 -0.43%

Day low

Day high

$9.00

$9.49

Open
Open: 9.30

52 week low

52 week high

$7.12

$17.85

Open

Market cap

$509.35M

Average volume

624,462

P/E ratio

4.47

Rev. per Employee

$715,252

EPS

2.09

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vnda

MarketWatch News on VNDA

  1. Stocks to Buy When the Bear Market Is Finally Over

    6:00 a.m. March 23, 2020

    - Barron's Online

  2. Vanda Pharmaceuticals downgraded to underperform from perform at Oppenheimer

    8:48 a.m. March 16, 2020

    - Tomi Kilgore

  3. Vanda Pharmaceuticals stock price target cut to $12 from $18 at Oppenheimer

    8:25 a.m. Feb. 27, 2020

    - Tomi Kilgore

  4. Vanda Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    7:57 a.m. July 25, 2019

    - Tomi Kilgore

  5. Vanda Pharmaceuticals price target raised to $44 from $36 at Stifel

    9:59 a.m. Dec. 11, 2018

    - Tonya Garcia

  6. Vanda Pharma shares decline as goal of itch drug study not reached

    4:49 p.m. Sept. 13, 2017

    - Wallace Witkowski

  7. Steven A. Cohen May Have Met His Match

    1:26 p.m. April 13, 2017

    - Barron's Online

  8. S&P 500 extends breakout, reclaims the 50-day average

    11:25 a.m. Sept. 23, 2016

    - Michael Ashbaugh

  9. Vanda Pharmaceuticals: ‘A Major Upside Surprise’

    2:38 p.m. Aug. 25, 2016

    - Barrons Blogs

  10. Biotech: The Next Pricing Controversy?

    12:26 p.m. May 23, 2016

    - Barrons Blogs

  11. Drugmakers jack up prices despite government pressure

    9:33 p.m. Jan. 10, 2016

    - Peter Loftus

  12. Cal-Maine Foods shares fall on earnings miss

    5:41 p.m. Dec. 23, 2014

    - Wallace Witkowski

  13. Vanda Pharmaceuticals' stock soars 21% licensing arbitration settlement

    10:33 a.m. Dec. 23, 2014

    - Tomi Kilgore

  14. S&P sets up for Santa Rally, and techs to light up the tree next year

    10:07 a.m. Dec. 23, 2014

    - Barbara Kollmeyer

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/vnda

Other News on VNDA

  1. Vanda Pharma issues developmental plans for tradipitant

    4:16 a.m. Sept. 1, 2020

    - Seeking Alpha

  2. Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

    10:40 a.m. Aug. 18, 2020

    - 247WallSt.com

  3. SRNE, DBX among premarket gainers

    8:25 a.m. Aug. 18, 2020

    - Seeking Alpha

  4. 10-Q: VANDA PHARMACEUTICALS INC.

    7:03 a.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. FDA OKs single-patient expanded access to Vanda's tradipitant

    4:59 p.m. July 13, 2020

    - Seeking Alpha

  6. Healthcare And Biotechnology Dashboard - Update

    7:03 p.m. May 26, 2020

    - Seeking Alpha

  7. Vanda on go to refile Hetlioz application in U.S.

    8:51 a.m. May 13, 2020

    - Seeking Alpha

  8. 10-Q: VANDA PHARMACEUTICALS INC.

    7:04 a.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/vnda

Press Releases on VNDA

  1. Vanda Pharmaceuticals Reports Second Quarter 2020 Financial Results

    4:01 p.m. Aug. 5, 2020

    - PR Newswire - PRF

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.